Bio-Technology General (Israel) Ltd.
3Patents
2Active
3Granted
36Portfolio score
Filing activity: Dec 31, 2001 → Sep 10, 2013 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7132510B2 | Specific human antibodies for selective cancer therapy | Chemistry; Metallurgy | 1 | Expired |
| US9896518B2 | Dilute filtration sterilization process for viscoelastic biopolymers | Chemistry; Metallurgy | 0 | Active |
| US8524885B2 | Hydrazido derivatives of hyaluronic acid | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.